-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Adaptive Biotechnologies Corp quarterly/annual Amortization of Intangible Assets history and growth rate from 2017 to Q3 2025.
- Adaptive Biotechnologies Corp Amortization of Intangible Assets for the quarter ending September 30, 2025 was $428K, unchanged year-over-year.
- Adaptive Biotechnologies Corp Amortization of Intangible Assets for the twelve months ending September 30, 2025 was $1.7M, a 0.35% decline year-over-year.
- Adaptive Biotechnologies Corp annual Amortization of Intangible Assets for 2024 was $1.7M, a 0.24% increase from 2023.
- Adaptive Biotechnologies Corp annual Amortization of Intangible Assets for 2023 was $1.7M, unchanged from 2022.
- Adaptive Biotechnologies Corp annual Amortization of Intangible Assets for 2022 was $1.7M, unchanged from 2021.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)